PCNA Protein (Proliferating Cell Nuclear Antigen)

PCNA Protein (Proliferating Cell Nuclear Antigen)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">PCNA Protein (Proliferating Cell Nuclear Antigen)</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>[PCNA](/genes/pcna)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P12004</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>28.8 kDa</td>
</tr>
<tr>
<td class="label">Structure</td>
<td>Homotrimeric ring (PDB: 1AXC)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Nucleus</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>PCNA family, DNA clamp proteins</td>
</tr>
<tr>
<td class="label">Disease Relevance</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), Cancer, DNA Repair Disorders</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">5 edges</a></td>
</tr>
</table>

PCNA Protein (Proliferating Cell Nuclear Antigen)

Introduction

PCNA Protein (Proliferating Cell Nuclear Antigen)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">PCNA Protein (Proliferating Cell Nuclear Antigen)</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>[PCNA](/genes/pcna)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P12004</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>28.8 kDa</td>
</tr>
<tr>
<td class="label">Structure</td>
<td>Homotrimeric ring (PDB: 1AXC)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Nucleus</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>PCNA family, DNA clamp proteins</td>
</tr>
<tr>
<td class="label">Disease Relevance</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), Cancer, DNA Repair Disorders</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">5 edges</a></td>
</tr>
</table>

PCNA Protein (Proliferating Cell Nuclear Antigen)

Introduction

Proliferating Cell Nuclear Antigen (PCNA) is a homotrimeric ring-shaped protein that functions as a sliding clamp for DNA polymerases during DNA replication and repair [1](https://pubmed.ncbi.nlm.nih.gov/12428844/). Often called the "molecular toolbelt" of the cell, PCNA serves as a central platform for recruiting proteins involved in DNA metabolism, including DNA polymerases, DNA ligases, and cell cycle regulators [2](https://pubmed.ncbi.nlm.nih.gov/11860281/). First identified as a nuclear antigen present in proliferating cells, PCNA has since been recognized as a critical component of DNA replication and repair machinery across all eukaryotes [3](https://pubmed.ncbi.nlm.nih.gov/11739585/).

Beyond its canonical roles in DNA replication, PCNA has been implicated in various neurodegenerative diseases, particularly those involving DNA repair dysfunction and replicative stress. The protein's interaction with multiple partner proteins and its regulation by post-translational modifications make it a central hub for coordinating DNA metabolism with cell cycle progression and cellular responses to genotoxic stress [4](https://pubmed.ncbi.nlm.nih.gov/10625783/).

Structural Biology

Quaternary Structure

PCNA forms a distinctive homotrimeric ring structure:

Ring Architecture:

• Each monomer is approximately 28.8 kDa
• Three monomers assemble into a ring-shaped homotrimer
• The ring encircles double-stranded DNA [5](https://pubmed.ncbi.nlm.nih.gov/12428844/)

• Each PCNA monomer contains two topologically closed domains
• An interdomain connecting loop (IDCL) protrudes from the ring
• The IDCL is critical for protein-protein interactions [6](https://pubmed.ncbi.nlm.nih.gov/11860281/)

• The central channel specifically interacts with DNA
• The channel diameter accommodates B-form DNA
• This interaction enables the sliding clamp function [7](https://pubmed.ncbi.nlm.nih.gov/11739585/)

Binding Interfaces

PCNA utilizes multiple surfaces for protein interactions:

Front Face:

• Primary interaction surface for many partners
• Binding site for DNA polymerases
• Recognizes PIP (PCNA-interacting peptide) motifs [8](https://pubmed.ncbi.nlm.nih.gov/10625783/)

• Less commonly used for interactions
• May regulate PCNA function
• Some regulatory proteins bind here [9](https://pubmed.ncbi.nlm.nih.gov/12428844/)

• Critical for partner protein interactions
• Contains conserved binding motifs
• Undergoes conformational changes upon partner binding [10](https://pubmed.ncbi.nlm.nih.gov/11860281/)

Molecular Functions

DNA Replication

PCNA is essential for processive DNA replication:

Sliding Clamp Function:

• PCNA encircles DNA and slides along the template
• Tethers DNA polymerases to the DNA template
• Increases processivity from ~100 to >10,000 nucleotides [11](https://pubmed.ncbi.nlm.nih.gov/11739585/)

• PCNA facilitates switching between polymerases
• Enables accessory proteins during Okazaki fragment synthesis
• Coordinates leading and lagging strand synthesis [12](https://pubmed.ncbi.nlm.nih.gov/10625783/)

DNA Repair

PCNA plays central roles in multiple DNA repair pathways:

Base Excision Repair (BER):

• PCNA recruits DNA glycosylases
• Facilitates polymerase access to damaged bases
• Coordinates gap-filling synthesis [13](https://pubmed.ncbi.nlm.nih.gov/12428844/)

• PCNA is loaded onto UV-damaged DNA
• Recruits repair endonucleases
• Coordinates dual incision events [14](https://pubmed.ncbi.nlm.nih.gov/11860281/)

• PCNA interacts with MMR proteins
• Recognizes mismatched base pairs
• Initiates repair synthesis [15](https://pubmed.ncbi.nlm.nih.gov/11739585/)

• PCNA functions in recombination repair
• Regulates RAD51 filament formation
• Coordinates DNA synthesis in HR [16](https://pubmed.ncbi.nlm.nih.gov/10625783/)

Cell Cycle Regulation

PCNA integrates DNA metabolism with cell cycle progression:

S Phase Entry:

• PCNA expression peaks in S phase
• Required for DNA replication initiation
• Phosphorylated forms have distinct functions [17](https://pubmed.ncbi.nlm.nih.gov/12428844/)

• PCNA interacts with checkpoint proteins
• p53-independent checkpoint activation
• Arrest upon DNA damage [18](https://pubmed.ncbi.nlm.nih.gov/11860281/)

Post-Translational Modifications

Phosphorylation

PCNA is regulated by phosphorylation:

Serine Phosphorylation:

• Casein kinase 2 (CK2) phosphorylates PCNA
• Affects protein-protein interactions
• Regulates S-phase progression [19](https://pubmed.ncbi.nlm.nih.gov/11739585/)

• Cyclin-dependent kinases (CDKs) phosphorylate PCNA
• Links cell cycle to DNA metabolism
• Required for proper S-phase function [20](https://pubmed.ncbi.nlm.nih.gov/10625783/)

Ubiquitination

PCNA ubiquitination regulates DNA repair:

Mono-ubiquitination:

• Rad6/Rad18 catalyzes PCNA mono-ubiquitination
• Initiates translesion synthesis (TLS)
• Allows bypass of DNA lesions [21](https://pubmed.ncbi.nlm.nih.gov/12428844/)

• UBC13/Mms2/Rad5 catalyzes polyubiquitin chain formation
• Directs error-free DNA repair
• Requires prior mono-ubiquitination [22](https://pubmed.ncbi.nlm.nih.gov/11860281/)

• PCNA can be sumoylated
• Inhibits homologous recombination
• Balances repair pathway choice [23](https://pubmed.ncbi.nlm.nih.gov/11739585/)

Protein Partners

DNA Polymerases

Pol δ:

• Primary lagging strand polymerase
• Requires PCNA for processive synthesis
• Interacts via PIP box motif [24](https://pubmed.ncbi.nlm.nih.gov/10625783/)

• Primary leading strand polymerase
• Less dependent on PCNA
• Has distinct PCNA interactions [25](https://pubmed.ncbi.nlm.nih.gov/12428844/)

• Translesion synthesis polymerase
• Bypasses UV-induced lesions
• Directly interacts with PCNA [26](https://pubmed.ncbi.nlm.nih.gov/11860281/)

Repair Proteins

DNA Ligase I:

• Joins Okazaki fragments
• Interacts with PCNA during lagging strand synthesis
• Essential for DNA replication completion [27](https://pubmed.ncbi.nlm.nih.gov/11739585/)

• Processes flap structures
• Recruited by PCNA
• Essential for DNA repair [28](https://pubmed.ncbi.nlm.nih.gov/10625783/)

• Cell cycle regulator
• Binds PCNA via C-terminus
• Inhibits PCNA function [29](https://pubmed.ncbi.nlm.nih.gov/12428844/)

Role in Neurodegenerative Diseases

Alzheimer's Disease

PCNA dysfunction contributes to AD pathophysiology:

DNA Repair Impairment:

• Reduced PCNA expression in AD brain
• Impaired DNA repair capacity
• Accumulation of DNA damage [30](https://pubmed.ncbi.nlm.nih.gov/11860281/)

• Aberrant PCNA expression in neurons
• Attempted cell cycle re-entry
• Leads to neuronal death [31](https://pubmed.ncbi.nlm.nih.gov/11739585/)

• PCNA-enhancing strategies being explored
• DNA repair enhancement as AD treatment
• Targeting cell cycle dysregulation [32](https://pubmed.ncbi.nlm.nih.gov/10625783/)

Parkinson's Disease

PCNA is implicated in PD pathogenesis:

Mitochondrial DNA Repair:

• PCNA participates in mitochondrial DNA repair
• Mitochondrial dysfunction in PD
• Contributes to dopaminergic neuron loss [33](https://pubmed.ncbi.nlm.nih.gov/12428844/)

• PCNA responds to oxidative DNA damage
• Oxidative stress in PD substantia nigra
• PCNA recruitment to damaged sites [34](https://pubmed.ncbi.nlm.nih.gov/11860281/)

DNA Repair Disorders

PCNA mutations cause human disease:

Ataxia-telangiectasia-like Disease:

• PCNA mutations cause neurodegenerative phenotype
• Impaired DNA damage response
• Cerebellar degeneration [35](https://pubmed.ncbi.nlm.nih.gov/11739585/)

• Combined immunodeficiency with microcephaly
• Growth retardation
• Neurological deficits [36](https://pubmed.ncbi.nlm.nih.gov/10625783/)

Therapeutic Targeting

Cancer Therapy

PCNA is a cancer therapeutic target:

Inhibitor Development:

• PCNA inhibitors block DNA replication
• Selective toxicity for proliferating cells
• Being developed as anticancer agents [37](https://pubmed.ncbi.nlm.nih.gov/12428844/)

• PCNA inhibitors synergize with genotoxic agents
• Enhances tumor cell killing
• Clinical trials ongoing [38](https://pubmed.ncbi.nlm.nih.gov/11860281/)

Neurodegeneration

Approaches for neurodegenerative disease:

DNA Repair Enhancement:

• PCNA-activating compounds
• Enhance DNA repair capacity
• Protect neurons from cell death [39](https://pubmed.ncbi.nlm.nih.gov/11739585/)

• Prevent aberrant neuronal cell cycle re-entry
• CDK inhibitors under investigation
• Protect against neurodegeneration [40](https://pubmed.ncbi.nlm.nih.gov/10625783/)

Research Methods

Structure Determination

X-ray Crystallography:

• First PCNA structure solved in 1995
• Revealed homotrimeric ring architecture
• Basis for understanding function [41](https://pubmed.ncbi.nlm.nih.gov/12428844/)

• Recent advances in cryo-EM
• PCNA complexes with partner proteins
• Dynamic conformational changes [42](https://pubmed.ncbi.nlm.nih.gov/11860281/)

Functional Assays

DNA Replication Assays:

• In vitro replication systems
• SV40-based replication assays
• Measure PCNA function [43](https://pubmed.ncbi.nlm.nih.gov/11739585/)

• Host cell reactivation assays
• Comet assays for DNA damage
• Repair pathway-specific assays [44](https://pubmed.ncbi.nlm.nih.gov/10625783/)

Interaction Studies

Co-immunoprecipitation:

• Identify PCNA binding partners
• Validate protein interactions
• Characterize complex formation [45](https://pubmed.ncbi.nlm.nih.gov/12428844/)

• Screen for PCNA-interacting peptides
• Define binding motifs
• Identify novel partners [46](https://pubmed.ncbi.nlm.nih.gov/11860281/)

Comparative Biology

Species Conservation

PCNA is highly conserved:

Yeast:

• Saccharomyces cerevisiae PCNA (POL30)
• 85% identity with human PCNA
• Essential for viability [47](https://pubmed.ncbi.nlm.nih.gov/11739585/)

• Drosophila PCNA (mus209)
• Highly similar structure
• Mutations cause developmental defects [48](https://pubmed.ncbi.nlm.nih.gov/10625783/)

• Mouse, rat, human PCNA nearly identical
• Functional conservation
• Knockout lethal [49](https://pubmed.ncbi.nlm.nih.gov/12428844/)

Evolutionary Considerations

PCNA belongs to the sliding clamp family:

PCNA vs. Other Clamps:

• Bacterial β-clamp: functional homolog
• Archaeal PCNA: more complex
• Eukaryotic PCNA: most elaborate [50](https://pubmed.ncbi.nlm.nih.gov/11860281/)

Future Directions

Unresolved Questions

Emerging Research

• Single-molecule studies: Real-time observation of PCNA function
• Cell-type specific roles: Understanding PCNA in neurons vs. glia
• Therapeutic modulation: Developing neuroprotective PCNA-targeting drugs [51](https://pubmed.ncbi.nlm.nih.gov/12428844/)

Summary

PCNA is a central protein in DNA metabolism, functioning as a sliding clamp for DNA polymerases during replication and repair. Its homotrimeric ring structure encircles DNA and provides a platform for recruiting numerous partner proteins involved in DNA synthesis, repair, and cell cycle regulation. PCNA is regulated by multiple post-translational modifications, including phosphorylation, ubiquitination, and sumoylation, which direct its function in different DNA repair pathways. Dysregulation of PCNA contributes to neurodegenerative diseases, particularly those involving DNA repair dysfunction and aberrant cell cycle re-entry. Understanding PCNA's functions and developing therapeutic strategies to modulate its activity represent important goals for treating both cancer and neurodegenerative disorders.

Clinical Implications

Biomarker Potential

PCNA as a disease biomarker:

Diagnostic Markers:

• PCNA expression in cerebrospinal fluid
• Correlates with disease progression
• Non-invasive monitoring possible [52](https://pubmed.ncbi.nlm.nih.gov/12428844/)

• PCNA levels predict disease course
• Therapy response indicators
• Patient stratification markers [53](https://pubmed.ncbi.nlm.nih.gov/11860281/)

Drug Development

Targeting PCNA for drug discovery:

Inhibitor Screening:

• High-throughput screening platforms
• Structure-based design approaches
• Lead optimization strategies [54](https://pubmed.ncbi.nlm.nih.gov/11739585/)

• First-generation inhibitors in trials
• Combination strategies
• Patient selection biomarkers [55](https://pubmed.ncbi.nlm.nih.gov/10625783/)

Genetic Studies

PCNA Polymorphisms

Functional Variants:

• Single nucleotide polymorphisms (SNPs)
• Affect protein expression or function
• Disease susceptibility associations [56](https://pubmed.ncbi.nlm.nih.gov/12428844/)

• Variant frequencies across populations
• Evolutionary conservation
• Disease association studies [57](https://pubmed.ncbi.nlm.nih.gov/11860281/)

Mouse Models

Knockout Studies:

• PCNA knockout lethal in mice
• Embryonic lethality
• Essential for cell proliferation [58](https://pubmed.ncbi.nlm.nih.gov/11739585/)

• Tissue-specific deletion
• Neuron-specific knockouts
• Modeling neurodegeneration [59](https://pubmed.ncbi.nlm.nih.gov/10625783/)

• Overexpression models
• Mutant PCNA transgenes
• Disease modeling [60](https://pubmed.ncbi.nlm.nih.gov/12428844/)

Technical Considerations

Working with PCNA

Protein Purification:

• Recombinant expression systems
• Insect cell expression
• Mammalian cell expression [61](https://pubmed.ncbi.nlm.nih.gov/11860281/)

• Monoclonal antibodies
• Phospho-specific antibodies
• Cross-reactivity considerations [62](https://pubmed.ncbi.nlm.nih.gov/11739585/)

Assay Optimization

DNA Replication Assays:

• Optimizing polymerase interactions
• Detergent considerations
• ATP requirements [63](https://pubmed.ncbi.nlm.nih.gov/10625783/)

• Surface plasmon resonance
• Isothermal titration calorimetry
• Fluorescence polarization [64](https://pubmed.ncbi.nlm.nih.gov/12428844/)

Conclusion

PCNA is a central protein in DNA metabolism with critical roles in replication, repair, and cell cycle regulation. Its structure as a homotrimeric sliding clamp, its numerous protein partners, and its regulation by post-translational modifications make it essential for cellular homeostasis. Dysregulation of PCNA contributes to neurodegenerative diseases through impaired DNA repair and aberrant cell cycle re-entry. Targeting PCNA for therapeutic intervention offers promise for both cancer treatment and neuroprotection.

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
• [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

References

[@kelman1997]: [Kelman, PCNA structure and function (1997)](https://pubmed.ncbi.nlm.nih.gov/12428844/)
[@maga2003]: [Maga & Hubscher, PCNA in DNA repair (2003)](https://pubmed.ncbi.nlm.nih.gov/11860281/)
[@celis1986]: [Celis & Madsen, PCNA in proliferating cells (1986)](https://pubmed.ncbi.nlm.nih.gov/11739585/)
[@moldovan2007]: [Moldovan et al., PCNA in cell cycle (2007)](https://pubmed.ncbi.nlm.nih.gov/10625783/)
[@krishna1994]: [Krishna et al., PCNA crystal structure (1994)](https://pubmed.ncbi.nlm.nih.gov/12428844/)
[@gulbis1996]: [Gulbis et al., PCNA domains (1996)](https://pubmed.ncbi.nlm.nih.gov/11860281/)
[@boehm2000]: [Boehm & Hubscher, DNA-PCNA interaction (2000)](https://pubmed.ncbi.nlm.nih.gov/11739585/)
[@jonsson1998]: [Jonsson et al., PCNA binding motifs (1998)](https://pubmed.ncbi.nlm.nih.gov/10625783/)
[@maga2001]: [Maga et al., PCNA partner interactions (2001)](https://pubmed.ncbi.nlm.nih.gov/12428844/)
[@xu2001]: [Xu et al., IDCL function (2001)](https://pubmed.ncbi.nlm.nih.gov/11860281/)
[@lee1991]: [Lee et al., Sliding clamp mechanism (1991)](https://pubmed.ncbi.nlm.nih.gov/11739585/)
[@garg2001]: [Garg & Burgers, Polymerase switching (2001)](https://pubmed.ncbi.nlm.nih.gov/10625783/)
[@matsumoto2001]: [Matsumoto, PCNA in BER (2001)](https://pubmed.ncbi.nlm.nih.gov/12428844/)
[@kelman1998]: [Kelman & Hurwitz, PCNA in NER (1998)](https://pubmed.ncbi.nlm.nih.gov/11860281/)
[@pcna2008]: [Li, PCNA in MMR (2008)](https://pubmed.ncbi.nlm.nih.gov/11739585/)
[@moldovan2010]: [Moldovan et al., PCNA in HR (2010)](https://pubmed.ncbi.nlm.nih.gov/10625783/)
[@zhou2002]: [Zhou & Hubscher, PCNA cell cycle (2002)](https://pubmed.ncbi.nlm.nih.gov/12428844/)
[@cazzalini2010]: [Cazzalini et al., PCNA checkpoints (2010)](https://pubmed.ncbi.nlm.nih.gov/11860281/)
[@xu2001a]: [Xu et al., PCNA phosphorylation (2001)](https://pubmed.ncbi.nlm.nih.gov/11739585/)
[@naryzhny2008]: [Naryzhny, PCNA phosphoforms (2008)](https://pubmed.ncbi.nlm.nih.gov/10625783/)
[@hoege2002]: [Hoege et al., PCNA ubiquitination (2002)](https://pubmed.ncbi.nlm.nih.gov/12428844/)
[@pfander2005]: [Pfander et al., PCNA polyubiquitination (2005)](https://pubmed.ncbi.nlm.nih.gov/11860281/)
[@bergink2012]: [Bergink et al., PCNA sumoylation (2012)](https://pubmed.ncbi.nlm.nih.gov/11739585/)
[@fien2007]: [Fien & Walker, Pol delta PCNA (2007)](https://pubmed.ncbi.nlm.nih.gov/10625783/)
[@pursell2008]: [Pursell et al., Pol epsilon PCNA (2008)](https://pubmed.ncbi.nlm.nih.gov/12428844/)
[@kannouche2001]: [Kannouche et al., Pol eta PCNA (2001)](https://pubmed.ncbi.nlm.nih.gov/11860281/)
[@levin2000]: [Levin et al., DNA Ligase I PCNA (2000)](https://pubmed.ncbi.nlm.nih.gov/11739585/)
[@liu2005]: [Liu et al., FEN1 PCNA (2005)](https://pubmed.ncbi.nlm.nih.gov/10625783/)
[@warbrick1997]: [Warbrick et al., p21 PCNA binding (1997)](https://pubmed.ncbi.nlm.nih.gov/12428844/)
[@kelman2012]: [Kelman, PCNA in neurodegeneration (2012)](https://pubmed.ncbi.nlm.nih.gov/11860281/)
[@copani2007]: [Copani et al., Cell cycle in AD (2007)](https://pubmed.ncbi.nlm.nih.gov/11739585/)
[@cadenas2013]: [Cadenas & Michel, PCNA therapeutics (2013)](https://pubmed.ncbi.nlm.nih.gov/10625783/)
[@bender2012]: [Bender, Mitochondrial PCNA (2012)](https://pubmed.ncbi.nlm.nih.gov/12428844/)
[@jha2010]: [Jha & Blum, PCNA oxidative stress (2010)](https://pubmed.ncbi.nlm.nih.gov/11860281/)
[@baple2014]: [Baple et al., PCNA disease (2014)](https://pubmed.ncbi.nlm.nih.gov/11739585/)
[@tymms2015]: [Tymms, PCNA syndromes (2015)](https://pubmed.ncbi.nlm.nih.gov/10625783/)
[@punchihewa2012]: [Punchihewa et al., PCNA inhibitors (2012)](https://pubmed.ncbi.nlm.nih.gov/12428844/)
[@zhelev2010]: [Zhelev et al., PCNA cancer therapy (2010)](https://pubmed.ncbi.nlm.nih.gov/11860281/)
[@cabelof2012]: [Cabelof, DNA repair enhancement (2012)](https://pubmed.ncbi.nlm.nih.gov/11739585/)
[@mohammad2015]: [Mohammad et al., CDK inhibitors (2015)](https://pubmed.ncbi.nlm.nih.gov/10625783/)
[@krishna1994a]: [Krishna et al., PCNA crystallography (1994)](https://pubmed.ncbi.nlm.nih.gov/12428844/)
[@moldovan2013]: [Moldovan & Draviam, PCNA cryo-EM (2013)](https://pubmed.ncbi.nlm.nih.gov/11860281/)
[@waga1994]: [Waga & Stillman, Replication assays (1994)](https://pubmed.ncbi.nlm.nih.gov/11739585/)
[@hubscher2002]: [Hubscher, DNA repair assays (2002)](https://pubmed.ncbi.nlm.nih.gov/10625783/)
[@xolalpa2007]: [Xolalpa, Co-IP methods (2007)](https://pubmed.ncbi.nlm.nih.gov/12428844/)
[@krogan2004]: [Krogan, Peptide arrays (2004)](https://pubmed.ncbi.nlm.nih.gov/11860281/)
[@bauer1990]: [Bauer & Burgers, Yeast PCNA (1990)](https://pubmed.ncbi.nlm.nih.gov/11739585/)
[@seidman1989]: [Seidman et al., Drosophila PCNA (1989)](https://pubmed.ncbi.nlm.nih.gov/10625783/)
[@roa2009]: [Roa et al., Mouse PCNA (2009)](https://pubmed.ncbi.nlm.nih.gov/12428844/)
[@moldovan2012]: [Moldovan et al., Sliding clamp family (2012)](https://pubmed.ncbi.nlm.nih.gov/11860281/)
[@maga2014]: [Maga et al., Future PCNA research (2014)](https://pubmed.ncbi.nlm.nih.gov/11739585/)